Advanced search
Publication Cover
Clinical Epidemiology Volume 12, 2020 - Issue
Submit an article Journal homepage
88
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A Validation of Methods for the Evaluation of Observational Studies of Screening Mammography: An Exploratory Analysis Based on Simulating Screening Cohorts

Vasily Giannakeas1 Women’s College Research Institute, Toronto, Ontario, Canada;2 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, CanadaView further author information
,
Victoria Sopik1 Women’s College Research Institute, Toronto, Ontario, Canada;3 Institute of Medical Science, University of Toronto, Toronto, Ontario, CanadaView further author information
&
Steven Narod1 Women’s College Research Institute, Toronto, Ontario, Canada;2 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada;3 Institute of Medical Science, University of Toronto, Toronto, Ontario, CanadaCorrespondence[email protected]
View further author information
Pages 1161-1169 | Published online: 27 Oct 2020

References

  • Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658–663. doi:10.1148/radiol.1111046921712474
  • Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348(feb11 9):g366. doi:10.1136/bmj.g36624519768
  • Duffy SW, Vulkan D, Cuckle H, et al. Effect of mammography screening from age 40 years on breast cancer mortality (UK age trial): final results of a randomized, controlled trial. Lancet Oncol. 2020;21(9):1165–1172. doi:10.1016/S1470-2045(20)30398-332800099
  • IARC Working Group on The Evaluation of Cancer-Preventive Strategies. Breast Cancer Screening. Lyn, France: IARC Press; 2016.
  • Harris RP. How best to determine the mortality benefit from screening mammography: dueling results and methodologies from Canada. J Natl Cancer Inst. 2014;106(11):dju317. doi:10.1093/jnci/dju31725274580
  • Morrison AS, Brisson J, Khalid N. Breast cancer incidence and mortality in the breast cancer detection demonstration project. J Natl Cancer Inst. 1988;80(19):1540–1547. doi:10.1093/jnci/80.19.15403193469
  • Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res. 2012;14(1):R9. doi:10.1186/bcr309022230345
  • Broeders M, Moss S, Nystrom L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(Suppl 1):14–25. doi:10.1258/jms.2012.012078
  • Hofvind S, Ursin G, Tretli S, Sebuødegård S, Møller B. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer. 2013;119(17):3106–3112. doi:10.1002/cncr.2817423720226
  • Coldman A, Phillips N, Wilson C, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014;106(11):dju261. doi:10.1093/jnci/dju26125274578
  • Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999–2011. Br J Cancer. 2017;116(6):828–839. doi:10.1038/bjc.2017.628183141
  • Johns LE, Coleman DE, Swerdlow AJ, Moss SM. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: and individual-level cohort study. Br J Cancer. 2017;116(2):246–252. doi:10.1038/bjc.2016.41527931047
  • Tabár L, Dean PB, Chen TH, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2018;125(4):515–523. doi:10.1002/cncr.3184030411328
  • Dibden A, Offman J, Duffy SW, Gabe R. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers (Basel). 2020;12(4):976. doi:10.3390/cancers12040976
  • Duffy SW, Tabár L, Yen AM, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971–2979. doi:10.1002/cncr.3285932390151
  • Narod S. Countercurrents: the bias of choice. Curr Oncol. 2019;26(6):e712–e713. doi:10.3747/co.26.516531896940
  • “SEER*Explore”. Surveillance, epidemiology, and end results program, National Cancer Institute. Available from: https://seer.cancer.gov/explorer.
  • Surveillance Research Program. National Cancer Institute SEER*Stat software. Available from: seer.cancer.gov/seerstat. version 8.3.5.
  • Hernán MA, Hernández-Díaz S, Robins JM. Randomized trials analyzed as observational studies. Ann Intern Med. 2013;159(8):560–562.24018844
  • Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019;25(10):1601–1606. doi:10.1038/s41591-019-0597-x31591592

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.